Padma-28, et urtepraeparat, øger gangdistancen hos patienter med claudicatio intermittens

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Padma-28, et urtepraeparat, øger gangdistancen hos patienter med claudicatio intermittens. / Drabaek, H; Mehlsen, J; Petersen, J R; Himmelstrup, H; Hansen, K F.

In: Ugeskrift for Laeger, Vol. 156, No. 42, 17.10.1994, p. 6207-9.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Drabaek, H, Mehlsen, J, Petersen, JR, Himmelstrup, H & Hansen, KF 1994, 'Padma-28, et urtepraeparat, øger gangdistancen hos patienter med claudicatio intermittens', Ugeskrift for Laeger, vol. 156, no. 42, pp. 6207-9.

APA

Drabaek, H., Mehlsen, J., Petersen, J. R., Himmelstrup, H., & Hansen, K. F. (1994). Padma-28, et urtepraeparat, øger gangdistancen hos patienter med claudicatio intermittens. Ugeskrift for Laeger, 156(42), 6207-9.

Vancouver

Drabaek H, Mehlsen J, Petersen JR, Himmelstrup H, Hansen KF. Padma-28, et urtepraeparat, øger gangdistancen hos patienter med claudicatio intermittens. Ugeskrift for Laeger. 1994 Oct 17;156(42):6207-9.

Author

Drabaek, H ; Mehlsen, J ; Petersen, J R ; Himmelstrup, H ; Hansen, K F. / Padma-28, et urtepraeparat, øger gangdistancen hos patienter med claudicatio intermittens. In: Ugeskrift for Laeger. 1994 ; Vol. 156, No. 42. pp. 6207-9.

Bibtex

@article{0577dfea490c41deae487b579c83775c,
title = "Padma-28, et urtepraeparat, {\o}ger gangdistancen hos patienter med claudicatio intermittens",
abstract = "Thirty-six patients with stable intermittent claudication were randomized in a doubleblind study either to treatment with two tablets of Padma-28 twice daily (containing 340 mg dried herbal mixture composed according to an ancient lamaistic prescription) or placebo for four months. Effect of treatment was quantified by measurements of systemic and peripheral systolic blood pressures, and pain-free and maximal walking distances on a tread-mill. The actively treated group attained a significant increase in pain-free walking distance from 115 m (72-218) to 227 m (73- >1000, p <0.05). The placebo group did not show significant changes in either pain-free or maximal walking distance. Significant changes in systemic or peripheral blood pressures could not be demonstrated in any of the groups. In conclusion, our study has shown that treatment with Padma-28 over a four month period significantly increases the walking distance in patients with stable intermittent claudication of long duration.",
author = "H Drabaek and J Mehlsen and Petersen, {J R} and H Himmelstrup and Hansen, {K F}",
year = "1994",
month = oct,
day = "17",
language = "Dansk",
volume = "156",
pages = "6207--9",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "42",

}

RIS

TY - JOUR

T1 - Padma-28, et urtepraeparat, øger gangdistancen hos patienter med claudicatio intermittens

AU - Drabaek, H

AU - Mehlsen, J

AU - Petersen, J R

AU - Himmelstrup, H

AU - Hansen, K F

PY - 1994/10/17

Y1 - 1994/10/17

N2 - Thirty-six patients with stable intermittent claudication were randomized in a doubleblind study either to treatment with two tablets of Padma-28 twice daily (containing 340 mg dried herbal mixture composed according to an ancient lamaistic prescription) or placebo for four months. Effect of treatment was quantified by measurements of systemic and peripheral systolic blood pressures, and pain-free and maximal walking distances on a tread-mill. The actively treated group attained a significant increase in pain-free walking distance from 115 m (72-218) to 227 m (73- >1000, p <0.05). The placebo group did not show significant changes in either pain-free or maximal walking distance. Significant changes in systemic or peripheral blood pressures could not be demonstrated in any of the groups. In conclusion, our study has shown that treatment with Padma-28 over a four month period significantly increases the walking distance in patients with stable intermittent claudication of long duration.

AB - Thirty-six patients with stable intermittent claudication were randomized in a doubleblind study either to treatment with two tablets of Padma-28 twice daily (containing 340 mg dried herbal mixture composed according to an ancient lamaistic prescription) or placebo for four months. Effect of treatment was quantified by measurements of systemic and peripheral systolic blood pressures, and pain-free and maximal walking distances on a tread-mill. The actively treated group attained a significant increase in pain-free walking distance from 115 m (72-218) to 227 m (73- >1000, p <0.05). The placebo group did not show significant changes in either pain-free or maximal walking distance. Significant changes in systemic or peripheral blood pressures could not be demonstrated in any of the groups. In conclusion, our study has shown that treatment with Padma-28 over a four month period significantly increases the walking distance in patients with stable intermittent claudication of long duration.

M3 - Tidsskriftartikel

VL - 156

SP - 6207

EP - 6209

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 42

ER -

ID: 34073762